Verrica Pharmaceuticals Inc. (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

6.26

+0.28 (4.68%)

At close: Mar 11, 2026, 4:00 PM EDT

5.93

-0.33 (-5.27%)

After-hours: Mar 11, 2026, 7:39 PM EDT

Verrica Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	30.15	46.33	69.55	34.27	15.75
Short-Term Investments	-	-	-	-	54.6
Cash & Short-Term Investments	30.15	46.33	69.55	34.27	70.35
Cash Growth	-34.93%	-33.38%	102.92%	-51.29%	7.46%
Accounts Receivable	5.4	0.08	4.42	0.49	-
Inventory	2.24	2.46	1.02	-	-
Other Current Assets	4.76	2.31	2.55	4.36	3.97
Total Current Assets	42.54	51.18	77.53	39.12	74.33
Net Property, Plant & Equipment	1.86	2.58	3.62	5.33	5.5
Other Long-Term Assets	2.73	0.38	0.45	0.28	0.3
Total Assets	47.13	54.13	81.6	44.72	80.13
Accounts Payable	2.07	1.9	2.46	0.51	0.85
Accrued Expenses	12.84	13.51	13.86	2.66	3.27
Current Portion of Long-Term Debt	-	12.94	-	-	41.69
Current Portion of Leases	0.75	0.67	0.7	0.3	0.25
Unearned Revenue	0.78	-	-	-	-
Total Current Liabilities	16.44	29.01	17.02	3.46	46.06
Long-Term Debt	-	30.98	42.87	-	-
Long-Term Leases	0.89	1.35	1.94	1.23	1.47
Other Long-Term Liabilities	5.07	2.65	-	-	-
Total Long-Term Liabilities	5.95	34.98	44.81	1.23	1.47
Total Liabilities	22.39	63.99	61.83	4.69	47.52
Common Stock	0	0	0	0	0
Additional Paid-in Capital	349.65	297.17	250.21	203.48	171.6
Accumulated Other Comprehensive Income	-	-	-	-	-0.03
Retained Earnings	-324.91	-307.03	-230.45	-163.45	-138.97
Shareholders' Equity	24.74	-9.86	19.76	40.03	32.61
Total Liabilities & Equity	47.13	54.13	81.6	44.72	80.13
Total Debt	1.63	45.94	45.51	1.53	43.41
Net Cash (Debt)	28.52	0.39	24.04	32.75	26.95
Net Cash Growth	7211.79%	-98.38%	-26.60%	21.53%	-4.67%
Net Cash Per Share	2.68	0.07	5.30	9.59	9.96
Book Value	24.74	-9.86	19.76	40.03	32.61
Book Value Per Share	2.32	-1.90	4.36	11.72	12.06
Tangible Book Value	24.74	-9.86	19.76	40.03	32.61
Tangible Book Value Per Share	2.32	-1.90	4.36	11.72	12.06

Updated Mar 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q